Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome
Authors:
- Nayê Balzan SchneiderNSNayê Balzan Schneider
- Maria Isabel AchatzMAMaria Isabel Achatz
- Ândrea Ribeiro dos SantosÂSÂndrea Ribeiro dos Santos
- Manuela PinheiroMPManuela Pinheiro
- Patricia Ashton‐ProllaPAPatricia Ashton‐Prolla
- Edenir Inêz PalmeroEPEdenir Inêz Palmero
- Brazilian Lynch Syndrome Study GroupBGBrazilian Lynch Syndrome Study Group
Open Access
- 25 March 2018
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 7 (5) , 2078-2088
Abstract
Lynch syndrome (LS) is the most common hereditary colorectal cancer syndrome, caused by germline mutations in one of the major genes involved in mismatch repair (MMR): MLH1, MSH2, MSH6 and more rarely, PMS2. Recently, germline deletions in EPCAM have been also associated to the syndrome. Most of the pathogenic MMR mutations found in LS families occur in MLH1 or MSH2. Gene variants include missense, nonsense, frameshift mutations, large genomic rearrangements and splice‐site variants and most of the studies reporting the molecular characterization of LS families have been conducted outside South America. In this study, we analyzed 60 unrelated probands diagnosed with colorectal cancer and LS criteria. Testing for germline mutations and/or rearrangements in the most commonly affected MMR genes (MLH1, MSH2, EPCAM and MSH6) was done by Sanger sequencing and MLPA. Pathogenic or likely pathogenic variants were identified in MLH1 or MSH2 in 21 probands (35.0%). Of these, approximately one‐third were gene rearrangements. In addition, nine variants of uncertain significance (VUS) were identified in 10 (16.6%) of the sixty probands analyzed. Other four novel variants were identified, only in MLH1. Our results suggest that MSH6 pathogenic variants are not common among Brazilian LS probands diagnosed with CRC and that MMR gene rearrangements account for a significant proportion of the germline variants in this population underscoring the need to include rearrangement analysis in the molecular testing of Brazilian individuals with suspected Lynch syndrome.Keywords
This publication has 54 references indexed in Scilit:
- Performance of PREMM1,2,6, MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer casesGenetics in Medicine, 2012
- Comparison of the clinical prediction model PREMM 1,2,6 and molecular testing for the systematic identification of Lynch syndrome in colorectal cancerGut, 2012
- Predictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countriesBMC Cancer, 2012
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeJAMA, 2011
- Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome CasesThe Journal of Molecular Diagnostics, 2011
- Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriersJournal of Medical Genetics, 2010
- Risks of Lynch Syndrome Cancers for MSH6 Mutation CarriersJNCI: Journal of the National Cancer Institute, 2010
- Colorectal Cancer Risk Perception on the Basis of Genetic Test Results in Individuals at Risk for Lynch SyndromeJournal of Clinical Oncology, 2009
- The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 MutationsGastroenterology, 2008
- The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)Diseases of the Colon & Rectum, 1991